New diabetes drug tested in kids: how long does it stay in the body?
NCT ID NCT06362265
First seen Nov 01, 2025 · Last updated Jun 16, 2026 · Updated 27 times
Summary
This study looked at how a new medicine, LY3209590, is processed in the bodies of 15 children with type 2 diabetes. Each child received one dose, and researchers measured the drug levels in their blood over time. The goal was to understand how the drug is absorbed and removed, not to treat the disease. The study lasted about 100 days.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES MELLITUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centricity Research Columbus Endocrinology
Columbus, Georgia, 31904, United States
-
Children's Healthcare of Atlanta - Center for Advanced Pediatrics
Atlanta, Georgia, 30329, United States
-
Children's Hospital Los Angeles
Los Angeles, California, 90027, United States
-
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, 19104, United States
-
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, 45229-3039, United States
-
Johns Hopkins Hospital
Baltimore, Maryland, 21287, United States
-
Joslin Diabetes Center
Boston, Massachusetts, 02215, United States
-
Lifedoc Research - Lenox Park Drive
Memphis, Tennessee, 38115, United States
-
NYU Langone
New York, New York, 10016, United States
-
UBMD Pediatrics
Buffalo, New York, 14203, United States
Conditions
Explore the condition pages connected to this study.